Hanmi, “Olmutinib in progress, Phase 3 plan temporarily suspended”

When it comes to the ‘the300’s(Money Today)’ article ‘Boehringer already suspended clinical trial this August… did it really not know about it,’ Hanmi Pharm announced on the 7^th that the Phase 2 clinical trial was in progress at the time when the letters mentioned in the article was exchanged, and the trial is still being conducted; at the time, we had a plan for a global Phase 3 clinical trial...